Thus, we hypothesised that DDX17 is involved in the progression of NASH and NASH‐HCC; nonetheless, the specific mechanism of DDX17 in lipid metabolism and NASH remain to be thoroughly clarified. The gene discussed is DDX17; the disease is metabolic dysfunction-associated steatohepatitis.